Registration Dossier
Registration Dossier
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-854-4 | CAS number: 111-29-5
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Comparable to guideline study with acceptable restrictions
Cross-reference
- Reason / purpose for cross-reference:
- reference to same study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 979
- Report date:
- 1979
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Principles of method if other than guideline:
- Internal BASF-method was used, which was in large part equivalent to methods described in OECD guideline 401
- GLP compliance:
- no
- Test type:
- standard acute method
- Limit test:
- no
Test material
- Reference substance name:
- Pentane-1,5-diol
- EC Number:
- 203-854-4
- EC Name:
- Pentane-1,5-diol
- Cas Number:
- 111-29-5
- Molecular formula:
- C5H12O2
- IUPAC Name:
- pentane-1,5-diol
- Details on test material:
- - Name of test material (as cited in study report): Pentandiol-1,5 techn.
- Physical state: liquid
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Gassner
- Weight at study initiation: mean weight 205 g (male), 165 g (female)
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- water
- Details on oral exposure:
- VEHICLE
- Concentration in vehicle: 10%, 46.4%, 68.1%, 100%
- Amount of vehicle (if gavage): 6.8, 10.0 ml/kg bw
MAXIMUM DOSE VOLUME APPLIED: 10.0 ml/kg bw - Doses:
- 1000, 4640, 6810, 10000
- No. of animals per sex per dose:
- 1000 - 4640 mg/kg bw: 2 female
6810 - 10000 mg/kg bw: 5 male and 5 female - Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: prior to study and at the end of study
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight
Results and discussion
Effect levels
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- ca. 10 000 mg/kg bw
- Mortality:
- 10000 mg/kg bw:
- male: 3/5 deaths within 24 h
- female: 0/5 deaths
6810 mg/kg bw:
- male: 0/5 deaths
- female: 1/5 deaths within 24 h
1000 - 4640 mg/kg bw: no deaths - Clinical signs:
- other: - reduced state and deaths observed on first 24 h - staggering, paresis, spastic gait, salivation, exsiccosis
- Gross pathology:
- Heart: acute dilatation, congestive hyperemia
Stomach: : bloody olcerations
Gut: diarrhotic content, hematonic content
Bladder: abnormal content
Applicant's summary and conclusion
- Interpretation of results:
- practically nontoxic
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
